Article ; Online: Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters.
2021 Volume 28, Issue 4, Page(s) 231–242
Abstract: ... on primitive hematopoietic cells or mature immune cells, by indirect effects on these cells, or ... centered on SARS-CoV-2, demonstrating that hematopoietic stem and progenitor cells and mature immune cells ... on hematopoietic cells and the clinical implications for these effects.: Recent findings: Recent studies have ...
| Abstract | Purpose of review: In recent history there have been three outbreaks of betacoronavirus infections in humans, with the most recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; causing Coronavirus disease 2019 [COVID-19]) outbreak leading to over two million deaths, with a rapidly rising death toll. Much remains unknown about host cells and tissues affected by coronavirus infections, including the hematopoietic system. Here, we discuss the recent findings examining effects that coronavirus infection or exposure has on hematopoietic cells and the clinical implications for these effects. Recent findings: Recent studies have centered on SARS-CoV-2, demonstrating that hematopoietic stem and progenitor cells and mature immune cells may be susceptible to infection and are impacted functionally by exposure to SARS-CoV-2 Spike protein. These findings have important implications regarding hematologic complications arising from COVID-19 and other coronavirus-induced disease, which we discuss here. Summary: Infection with coronaviruses sometimes leads to hematologic complications in patients, and these hematologic complications are associated with poorer prognosis. These hematologic complications may be caused by coronavirus direct infection or impact on primitive hematopoietic cells or mature immune cells, by indirect effects on these cells, or by a combination thereof. It is important to understand how hematologic complications arise in order to seek new treatments to improve patient outcomes. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | COVID-19/metabolism ; COVID-19/mortality ; COVID-19/pathology ; Hematopoietic Stem Cells/metabolism ; Hematopoietic Stem Cells/pathology ; Humans ; SARS-CoV-2/metabolism ; Spike Glycoprotein, Coronavirus/metabolism | |||||
| Chemical Substances | Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 | |||||
| Language | English | |||||
| Publishing date | 2021-03-03 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Research Support, N.I.H., Extramural ; Review | |||||
| ZDB-ID | 1153887-9 | |||||
| ISSN | 1531-7048 ; 1065-6251 | |||||
| ISSN (online) | 1531-7048 | |||||
| ISSN | 1065-6251 | |||||
| DOI | 10.1097/MOH.0000000000000645 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 3703: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.